Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia.

Prystowsky, E N

Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia. [electronic resource] - Clinical cardiology Sep 1994 - II7-10 p. digital

Publication Type: Journal Article; Review

0160-9289

10.1002/clc.4960171405 doi


Ambulatory Care
Anti-Arrhythmia Agents--adverse effects
Cardiomyopathies--complications
Flecainide--adverse effects
Hospitalization
Humans
Propafenone--adverse effects
Risk
Tachycardia, Supraventricular--chemically induced
Time Factors